Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Abatacept/disease-modifying antirheumatics

Recurrent severe infections: case report

    This is a preview of subscription content, log in to check access.

    REFERENCE

    1. 1.

      Diamantopoulos AP, Haugeberg G.Recurrent infections in a rheumatoid arthritis patient with a primary immunodeficiency, treated with conventional and biologic disease-modifying anti-rheumatic drugs. Modern rheumatology / the Japan Rheumatism Association 22: 295-297, No. 2, Apr 2012 - Norway

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Abatacept/disease-modifying antirheumatics. React. Wkly. 1420, 5 (2012). https://doi.org/10.2165/00128415-201214200-00019

    Download citation

    Keywords

    • Rheumatoid Arthritis
    • Adalimumab
    • Sulfasalazine
    • Leflunomide
    • Fasciitis